Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management

G Grani, L Lamartina, C Durante, S Filetti… - The Lancet Diabetes & …, 2018 - thelancet.com
Follicular thyroid cancer is the second most common differentiated thyroid cancer
histological type and has been overshadowed by its more common counterpart—papillary …

Thyroid hormone therapy in differentiated thyroid cancer

G Grani, V Ramundo, A Verrienti, M Sponziello… - Endocrine, 2019 - Springer
Surgery—with or without postoperative radioiodine—is the standard of care for most patients
with differentiated thyroid carcinoma (DTC). Thyroid hormone replacement therapy is the …

Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients

C Spinelli, S Strambi, L Rossi, S Bakkar… - Journal of …, 2016 - Springer
Purpose The extent of surgery for pediatric papillary thyroid carcinoma is debatable. The aim
of this study was to evaluate the feasibility of offering pediatric patients a tailored surgical …

[HTML][HTML] The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer

Y Gu, C Feng, T Liu, B Zhang, L Yang - PLoS One, 2018 - journals.plos.org
Homeobox protein Emx2 is a transcription factor that is encoded by the EMX2 gene. In this
study, using data from the Cancer Genome Atlas-Thyroid Cancer (TCGA-THCA), we aimed …

[HTML][HTML] Innovative analysis of distant metastasis in differentiated thyroid cancer

D Chen, L Huang, S Chen, Y Huang… - Oncology …, 2020 - spandidos-publications.com
Differentiated thyroid cancer (DTC) is the most common thyroid cancer with a relatively high
survival rate. The association between certain risk factors of distant metastasis (DM) remains …

[HTML][HTML] Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases

K Ohkuwa, K Sugino, M Nagahama… - Endocrine …, 2021 - ec.bioscientifica.com
Objective Radioactive iodine (RAI) therapy is effective for differentiated thyroid cancer (DTC)
patients with lung metastasis. However, some patients have a poor prognosis despite the …

[HTML][HTML] Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer

Y Gong, J Yang, W Wu, F Liu, A Su, Z Li, J Zhu, T Wei - PLoS One, 2018 - journals.plos.org
Voltage-gated sodium channel β subunits (encoded by SCN1B to SCN4B genes) have been
demonstrated as important multifunctional signaling molecules modulating cellular …

Comparison of prognostic scoring systems in follicular thyroid cancer

KW Teo, NK Yuan, WB Tan… - The Annals of The …, 2017 - publishing.rcseng.ac.uk
INTRODUCTION Many studies have addressed the accuracy of prognostic scoring systems
in the treatment of differentiated thyroid cancers as a whole but few have addressed this …

[HTML][HTML] The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis

JD Lin, SF Kuo, BY Huang, SF Lin… - Nuclear Medicine …, 2018 - journals.lww.com
Objective Radioactive iodine (131 I) has been used as a treatment for high-risk well-
differentiated thyroid cancer after thyroidectomy. The aim of this study was to evaluate the …

[HTML][HTML] Case Report: A tortuous diagnosis and successful multimodal treatment of thyroid follicular carcinoma with pelvic metastasis

ZL Hong, HJ Huang, S Chen, JC Yang, SS Wu - Frontiers in Oncology, 2023 - frontiersin.org
Purpose: To provide reference method for the treatment of thyroid follicular carcinoma by
studing the clinical imaging, pathological features and multimodal treatment of a case of …